Showing 1 - 10 of 272
The objective of this paper is to examine the impact of economic evaluation on the reimbursement process for pharmaceuticals. Before the introduction of economic evaluation, a range of arrangements existed across different jurisdictions, varying from reimbursement based on clinical criteria...
Persistent link: https://www.econbiz.de/10010900825
Critical leg ischaemia can be treated by amputation of the affected leg or by reconstruction of the arteries. Arterial reconstruction is perceived to be an expensive procedure, often requiring more than one operation, which does not always prevent amputation. However, amputation is associated...
Persistent link: https://www.econbiz.de/10005344485
Recent epidemiological studies suggest that much urological disease is untreated. However, the overall economic burden of urological diseases has never been systematically studied. This report estimates the economic burden of treated benign prostatic hyperplasia (BPH) in the United Kingdom by...
Persistent link: https://www.econbiz.de/10009439532
Background Provision of evidence on costs alongside evidence on the effects of interventions can enhance the relevance of systematic reviews to decision-making. However, patterns of use of economics methods alongside systematic review remain unclear. Reviews of evidence on the effects of...
Persistent link: https://www.econbiz.de/10009440624
Persistent link: https://www.econbiz.de/10005509049
Persistent link: https://www.econbiz.de/10005509131
Persistent link: https://www.econbiz.de/10005516249
Persistent link: https://www.econbiz.de/10005516548
Persistent link: https://www.econbiz.de/10005516781
Persistent link: https://www.econbiz.de/10005517116